Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chronic low-grade peripheral inflammation is associated with severe nicotine dependence in schizophrenia: results from the national multicentric FACE-SZ cohort
G. Fond, Fabrice Berna, M. Andrianarisoa, et al.
European Archives of Psychiatry and Clinical Neuroscience (2017) Vol. 267, Iss. 5, pp. 465-472
Closed Access | Times Cited: 20

Showing 20 citing articles:

The Role of Inflammation in the Treatment of Schizophrenia
Guillaume Fond, Christophe Lançon, Théo Korchia, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 113
C-Reactive Protein as a Peripheral Biomarker in Schizophrenia. An Updated Systematic Review
Guillaume Fond, Christophe Lançon, Pascal Auquier, et al.
Frontiers in Psychiatry (2018) Vol. 9
Open Access | Times Cited: 75
Microbiota-Orientated Treatments for Major Depression and Schizophrenia
Guillaume B. Fond, Jean‐Christophe Lagier, Stéphane Honoré, et al.
Nutrients (2020) Vol. 12, Iss. 4, pp. 1024-1024
Open Access | Times Cited: 57
Could CRP be a differential biomarker of illness stages in schizophrenia? A systematic review and meta-analysis
Valentine Lestra, Bruno Roméo, Catherine Martelli, et al.
Schizophrenia Research (2022) Vol. 246, pp. 175-186
Open Access | Times Cited: 31
Metabolic-inflammatory status as predictor of clinical outcome at 1-year follow-up in patients with first episode psychosis
Maria Antonietta Nettis, Giulio Pergola, Anna Kolliakou, et al.
Psychoneuroendocrinology (2018) Vol. 99, pp. 145-153
Open Access | Times Cited: 48
High C-reactive protein levels are associated with depressive symptoms in schizophrenia
Mélanie Faugère, Jean‐Arthur Micoulaud‐Franchi, Catherine Faget-Agius, et al.
Journal of Affective Disorders (2017) Vol. 225, pp. 671-675
Closed Access | Times Cited: 32
Nicotine dependence in Croatian male inpatients with schizophrenia
Marina Šagud, Bjanka Vuksan‐Ćusa, Nenad Jakšić, et al.
BMC Psychiatry (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 23
Centres Experts Schizophrénie, un outil pour le soin et la recherche : retour sur 10 ans d’expérience
F. Schürhoff, G. Fond, Fabrice Berna, et al.
L Encéphale (2018) Vol. 45, Iss. 1, pp. 9-14
Open Access | Times Cited: 17
One-day tropisetron treatment improves cognitive deficits and P50 inhibition deficits in schizophrenia
Luyao Xia, Lei Liu, Xiaohong Hong, et al.
Neuropsychopharmacology (2020) Vol. 45, Iss. 8, pp. 1362-1368
Open Access | Times Cited: 16
Self-reported cannabis use and biomarkers of inflammation among adults in the United States
Chukwuemeka N. Okafor, Michael J. Li, Jason Paltzer
Brain Behavior & Immunity - Health (2020) Vol. 7, pp. 100109-100109
Open Access | Times Cited: 13
Influence of Venus and Mars in the cognitive sky of schizophrenia. Results from the first-step national FACE-SZ cohort
Guillaume Fond, Laurent Boyer, Marion Leboyer, et al.
Schizophrenia Research (2017) Vol. 195, pp. 357-365
Closed Access | Times Cited: 13
Abnormal C-reactive protein blood levels as a specific biomarker of major depression and non-remission under antidepressants in schizophrenia
G. Fond, Jean‐Arthur Micoulaud‐Franchi, Mélanie Faugère, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2019) Vol. 97, pp. 109800-109800
Open Access | Times Cited: 12
Additive Effect of Cigarette Smoking on Gray Matter Abnormalities in Schizophrenia
Naoto Yokoyama, Hitoshi Sasaki, Yasuo Mori, et al.
Schizophrenia Bulletin (2017)
Open Access | Times Cited: 11
Serum level of high sensitive C-reactive protein and IL − 6 markers in patients with treatment-resistant schizophrenia in Ethiopia: a comparative study
Feyissa Challa, Daniel Seifu, Meron Sileshi, et al.
BMC Psychiatry (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 10
Altered proteomic profile in umbilical arterial serum from mothers with schizophrenia
Yoshinori Moriyama, Tomomi Kotani, Takafumi Ushida, et al.
Schizophrenia Research (2018) Vol. 197, pp. 615-617
Closed Access | Times Cited: 11
Elevated levels of C-reactive protein and IL-6 among the antipsychotic medicating schizophrenia patients of Siliguri, West Bengal, India
Jiwan Gurung, Dependra Chamlagai, Nirmal Kumar Bera, et al.
Nordic Journal of Psychiatry (2018) Vol. 72, Iss. 4, pp. 311-317
Closed Access | Times Cited: 8
Depressive symptoms and chronic peripheral inflammation are associated with impaired functional remission in schizophrenia independently of psychotic remission.
Guillaume Fond, Mélanie Faugère, Raphaëlle Richieri, et al.
Journal of Affective Disorders (2020) Vol. 280, pp. 267-271
Closed Access | Times Cited: 8
Inflammatory DEpression Advances in Schizophrenia (IDEAS): A precision medicine approach of the national FACE-SZ cohort
Guillaume Fond, O. Godin, Franck Schürhoff, et al.
Journal of Affective Disorders (2018) Vol. 245, pp. 468-474
Closed Access | Times Cited: 7
Substance use disorders in schizophrenia: Prevalence, etiology, biomarkers, and treatment
Heather Burrell Ward, Charles B. Nemeroff, Linda L. Carpenter, et al.
Personalized Medicine in Psychiatry (2023) Vol. 39-40, pp. 100106-100106
Closed Access | Times Cited: 2
Redefining peripheral inflammation signature in schizophrenia based on the real-world FACE-SZ cohort
G. Fond, P.L. Sunhary de Verville, Raphaëlle Richieri, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2021) Vol. 111, pp. 110335-110335
Open Access | Times Cited: 4
Page 1

Scroll to top